Similar Articles
1361 Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells
1362 Hepatocellular carcinoma in cirrhotic patients with portal hypertension: Is liver resection always contraindicated?
1363 Hepatitis B virus infection and the risk of hepatocellular carcinoma
1364 Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma
1365 Liver transplantation for hepatocellular carcinoma on cirrhosis: Strategies to avoid tumor recurrence
1366 Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization
1367 CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis
1368 Comparison of laparoscopic vs open liver lobectomy (segmentectomy) for hepatocellular carcinoma
1369 Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma
1370 Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA